ImmunityBio, Inc. — insider transactions

3 transactions on record · IBRX · CIK 1326110

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
3
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$1M
Median disclosure lag
4.0 d
trade date to filing date
Largest single trade, 24m
$851.1K
2026-10-02
Director share, 12m
100.0%
of transactions where role is stated
Current run
3 sells
consecutive same-direction transactions
Net 3m flow
-$1M
purchases minus sales
Total on record
3

Transactions

3 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-10-062026-10-024Cohen CherylDirectorOpen market sale81,056$10.50$851.1Kfiling
2026-10-062026-10-024Cohen CherylDirectorExercise of derivative55,979$0.00—filing
2026-10-062026-10-024Cohen CherylDirectorExercise of derivative55,979$2.98$166.8Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

ImmunityBio, Inc. insider transactions — 3 filings on record — investment.com